Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caphosol for prevention of chemoradiotherapy-related esophagitis in SCLC/NSCLC
NL-OMON39628Phase 3Active, not recruiting
- Sponsor
- Amphia Ziekenhuis
- Start
- Feb 2014
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in esophagitis comparing Caphosol + standard of care with Standard of care alone (2 arms). Primary endpoints: Incidence of esophagitis, Onset of esophagitis and 2 more. Started Feb 2014; status: active, not recruiting.
02
Drugs
supersaturated calcium phosphate rinse
03
Conditions
esophagitis
Beyond the preview
Go deeper on NL-OMON39628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39628.